blog
The Altascientist
THE ALTASCIENTIST JANUARY 2019 ISSUE NO. 7
Effective pharmaceutical therapies — Understanding the intrinsic and extrinsic factors that alter exposure to limit adverse effects and maximize treatment response
SELECT A CATEGORY BELOW
BLOG
-
Blog
Are Biosimilars Destined to Replace Biologics?
Starting with insulin over six decades ago, biologics have become the fastest-growing class of therapeutic compounds. They have provided treatment options for people who suffer from some of the mos...
-
Blog
7 TIPS TO SURVIVE THE HOLIDAY MADNESS
The holiday season is upon us once again! It’s a happy and exciting period for some, but can also be a stressful and borderline anxiety-inducing time for others. Dinners, parties, spen...
-
Blog
February 23 — On this Day in History
Welcome to a “This Day in History” edition of our blog! Every evening, since I was just a kid, I have tuned in to watch Jeop...
-
Blog
Thinking of Participating in Multiple Studies at Once?
According to Verified Clinical Trials (VCT), a worldwide clinical trials database registry to prevent dual enrollment...
-
Blog
What Effect Will the New NIH Policy Have On Multi-Site Research?
In June 2016, the National Institutes of Health (NIH) released a new policy on the use of a single i...
-
Blog
What Does it Take? | Biologic and Biosimilar Clinical Trials
It’s the much-anticipated Part II of our “What Does it Take” series (insert glorious trumpet announcement sound here). In Part I, we discussed general First-In-Human (FIH) clinical trials, and...
-
Blog
What Does it Take? | First in Human Clinical Trials
Does the CRO you’re working with have what it takes to successfully conduct First-in-Human (FIH) clinical research? What are FIH trials?It’s important to define what...